Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors

Franck E. Nicolini, H. Jean Khoury, Luke Akard, Delphine Rea, Hagop Kantarjian, Michele Baccarani, Janis Leonoudakis, Adam Craig, Annie Claude Benichou, Jorge Cortes

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e78-e79
JournalHaematologica
Volume98
Issue number7
DOIs
StatePublished - Jul 1 2013
Externally publishedYes

Keywords

  • Advanced chronic myeloid leukemia
  • Dasatinib
  • Homoharringtonine
  • Imatinib
  • Nilotinib
  • Omacetaxine
  • Tyrosine kinase inhibitors

ASJC Scopus subject areas

  • Hematology

Cite this

Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors. / Nicolini, Franck E.; Khoury, H. Jean; Akard, Luke; Rea, Delphine; Kantarjian, Hagop; Baccarani, Michele; Leonoudakis, Janis; Craig, Adam; Benichou, Annie Claude; Cortes, Jorge.

In: Haematologica, Vol. 98, No. 7, 01.07.2013, p. e78-e79.

Research output: Contribution to journalLetter

Nicolini, FE, Khoury, HJ, Akard, L, Rea, D, Kantarjian, H, Baccarani, M, Leonoudakis, J, Craig, A, Benichou, AC & Cortes, J 2013, 'Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors', Haematologica, vol. 98, no. 7, pp. e78-e79. https://doi.org/10.3324/haematol.2012.083006
Nicolini, Franck E. ; Khoury, H. Jean ; Akard, Luke ; Rea, Delphine ; Kantarjian, Hagop ; Baccarani, Michele ; Leonoudakis, Janis ; Craig, Adam ; Benichou, Annie Claude ; Cortes, Jorge. / Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors. In: Haematologica. 2013 ; Vol. 98, No. 7. pp. e78-e79.
@article{5e2f3de068f846e09eeccb543f444ab8,
title = "Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors",
keywords = "Advanced chronic myeloid leukemia, Dasatinib, Homoharringtonine, Imatinib, Nilotinib, Omacetaxine, Tyrosine kinase inhibitors",
author = "Nicolini, {Franck E.} and Khoury, {H. Jean} and Luke Akard and Delphine Rea and Hagop Kantarjian and Michele Baccarani and Janis Leonoudakis and Adam Craig and Benichou, {Annie Claude} and Jorge Cortes",
year = "2013",
month = "7",
day = "1",
doi = "10.3324/haematol.2012.083006",
language = "English (US)",
volume = "98",
pages = "e78--e79",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "7",

}

TY - JOUR

T1 - Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors

AU - Nicolini, Franck E.

AU - Khoury, H. Jean

AU - Akard, Luke

AU - Rea, Delphine

AU - Kantarjian, Hagop

AU - Baccarani, Michele

AU - Leonoudakis, Janis

AU - Craig, Adam

AU - Benichou, Annie Claude

AU - Cortes, Jorge

PY - 2013/7/1

Y1 - 2013/7/1

KW - Advanced chronic myeloid leukemia

KW - Dasatinib

KW - Homoharringtonine

KW - Imatinib

KW - Nilotinib

KW - Omacetaxine

KW - Tyrosine kinase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84879589256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879589256&partnerID=8YFLogxK

U2 - 10.3324/haematol.2012.083006

DO - 10.3324/haematol.2012.083006

M3 - Letter

C2 - 23753022

AN - SCOPUS:84879589256

VL - 98

SP - e78-e79

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 7

ER -